patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: anyone have any insight to what is going on here? giving me a
By: naztrader55
05 Jun 2007, 09:57 AM EDT

did anyone else listen to the presentation?

I jotted these notes:

- meeting next week with the US hospital re the clinical agreement
- IND submission late Aug/early Sep
- PI/II trial starting end '07 will need only 30 days to get positive data indications of success (leukemia patients)
- PII/III trial starting end '08, estimated early 2010 approval

- currently meet all requirement for either nasdaq or amex listing, and will have one "relatively soon"

- price drivers include broadening scientific team, tech/IP developments, collaborative
- will improve capital structure later once have clinical news, not interested in a reverse right now
- $10.5mil cash, no debt
- most else same as last presentation


Share
New Message
Please login to post a reply